Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Prednisone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 10/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | PGR | P06401 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | AR | P10275 | 2/20 | 0.68 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.68 |
| ▸ | TNF | P01375 | 1/20 | 0.68 |
| ▸ | IL6 | P05231 | 1/20 | 0.68 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.68 |
| ▸ | GLUL | P15104 | 1/20 | 0.68 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prednisone SCHEMBL3408330 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL15304738 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL1236044 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL8262569 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL13620924 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL13323411 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL23974933 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL20459224 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL21281533 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A | |
| Prednisone SCHEMBL21883168 | 1.00 | HSD17B10 (1.00) | HSD17B10NR3C1HIF1ALMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 207738 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144816-A1 | COMPOSITIONS AND METHODS FOR TREATING DEMENTIA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-05-28 | — | — | US | claimed |
| US-20260144182-A1 | SEED COATING COMPOSITION | CRODA, INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-20260144892-A1 | METHOD OF REDUCING CST FLUCTUATION IN NEOVASCULAR AMD BY A RECOMBINANT ADENO-ASSOCIATED VIRUS | ADVERUM BIOTECHNOLOGIES, INC. (US) | 2026-05-28 | — | — | US | claimed |
| EP-4746852-A1 | LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION | Universität Bern (CH) | 2026-05-27 | — | — | EP | claimed |
| EP-3946313-B1 | ONVANSERTIB FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER | CARDIFF ONCOLOGY INC (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4748376-A2 | METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS | Janssen Biotech, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746718-A1 | METHOD FOR PRODUCING CASEIN AND USES THEREOF | Standing Ovation (FR) | 2026-05-27 | — | — | EP | claimed |
| EP-4748448-A2 | USE OF MARIBAVIR FOR THE TREATMENT OF AND TREATMENT REGIMENS THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| US-4266024-A | USING ALKYLENEDIAMIDES, DIMETHYL SULFOXIDE OR GLUCOCORTICOIDS AS STIMULATORS FOR LYMPHOID CELLS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-05-05 | — | — | US | claimed |
| US-4252797-A | ANTIINFLAMMATORY AGENTS | ROSENTHAL WALTER | 1981-02-24 | — | — | US | claimed |
| WO-1981000410-A1 | CYTOTOXIC NUCLEOSIDE-CORTICOSTEROID PHOSPHODIESTERS | RESEARCH CORP (US) | 1981-02-19 | — | — | WO | claimed |
| US-4221787-A | Esteramide prodrugs of anti-inflammatory corticosteroids | INTERX RESEARCH CORPORATION (US) | 1980-09-09 | — | — | US | claimed |
| EP-0010964-A1 | Ravidomycin, process of preparation and pharmaceutical compositions containing same | AYERST, MCKENNA AND HARRISON INC. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4112073-A | Medicinal composition comprising adrenal cortical hormone and thyroid stimulating hormone releasing hormone | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-09-05 | — | — | US | claimed |
| US-4041055-A | SULFENYLATION, MICHAEL ADDITION, REACTION WITH THIOPHILE, HYDROLYSIS | THE UPJOHN COMPANY (US) | 1977-08-09 | — | — | US | claimed |
| US-4011316-A | STEROIDS, ANTIINFLAMMATORY AGENTS | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1977-03-08 | — | — | US | claimed |
| US-4001219-A | STEROIDAL DERIVATIVES OF BENDAZOLIC ACID AND PROCESS FOR THE PREPARATION OF THE SAME | BAIOCCHI LEANDRO | 1977-01-04 | — | — | US | claimed |
| US-3966778-A | Production of 21-phosphate corticords having unprotected hydroxyl radicals at least at the 17α- and 21-position | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-06-29 | — | — | US | claimed |